Alteration of tumor microenvironment for improved delivery and intratumor distribution of nanocarriers.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Biological and Pharmaceutical Bulletin

• Publication date

  2013-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1248/BPB.B13-00121PMID 23649327
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo.

  2013cited by this paper
• Macromolecular therapeutics in cancer treatment: the EPR effect and beyond.

  2012cited by this paper
• A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNA.

  2011cited by this paper
• Combination therapy of metronomic S‐1 dosing with oxaliplatin‐containing polyethylene glycol‐coated liposome improves antitumor activity in a murine colorectal tumor model

  2010cited by this paper
• Clinical relevance of thymidylate synthase (TS) activity for S-1-based chemotherapy in squamous cell carcinoma of the oral cavity.

  2010cited by this paper
• Synergistic antitumor activity of metronomic dosing of cyclophosphamide in combination with doxorubicin-containing PEGylated liposomes in a murine solid tumor model.

  2009cited by this paper
• Cancer cell death enhances the penetration and efficacy of oncolytic herpes simplex virus in tumors.

  2008cited by this paper
• Enhanced macromolecule diffusion deep in tumors after enzymatic digestion of extracellular matrix collagen and its associated proteoglycan decorin

  2008cited by this paper
• A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model.

  2008cited by this paper
• Combination therapy of S-1 and CDDP for patients with colorectal cancer

  2007cited by this paper
• Tumor necrosis factor alpha mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response.

  2007cited by this paper
• Tumor Priming Enhances Delivery and Efficacy of Nanomedicines

  2007cited by this paper
• Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers.

  2006cited by this paper
• Exploiting the enhanced permeability and retention effect for tumor targeting.

  2006cited by this paper
• Mosaic tumor vessels: cellular basis and ultrastructure of focal regions lacking endothelial cell markers.

  2005cited by this paper
• Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx™) in human osteosarcoma xenografts

  2005cited by this paper
• Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders.

  2005cited by this paper
• Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo

  2005cited by this paper
• VEGF as a Key Mediator of Angiogenesis in Cancer

  2005cited by this paper
• Hyaluronidase enhances the activity of Adriamycin in breast cancer models in vitro and in vivo

  2005cited by this paper
• VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B–PDGFRβ signaling

  2005cited by this paper
• Two-photon fluorescence correlation microscopy reveals the two-phase nature of transport in tumors

  2004cited by this paper
• Overexpressed Decorin in Pancreatic Cancer

  2004cited by this paper
• Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

  2004cited by this paper
• Pathology: Cancer cells compress intratumour vessels

  2004cited by this paper
• Imaging of angiogenesis: from microscope to clinic

  2003cited by this paper
• The biology of VEGF and its receptors

  2003cited by this paper
• Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting.

  2003cited by this paper
• Modulation of Tumor-selective Vascular Blood Flow and Extravasation by the Stable Prostaglandin I2 Analogue Beraprost Sodium

  2003cited by this paper
• Vascular Permeability Factor/Vascular Endothelial Growth Factor Induces Lymphangiogenesis as well as Angiogenesis

  2002cited by this paper
• The Extracellular Matrix of Animals

  2002cited by this paper
• Abnormal angiogenesis but intact hematopoietic potential in TGF‐β type I receptor‐deficient mice

  2001cited by this paper
• Role of tumor–host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors

  2001cited by this paper
• Macromolecule uptake in human melanoma xenografts. relationships to blood supply, vascular density, microvessel permeability and extracellular volume fraction.

  2000cited by this paper
• Tumor‐selective Blood Flow Decrease Induced by an Angiotensin Converting Enzyme Inhibitor, Temocapril Hydrochloride

  2000cited by this paper
• “Artificial Lymphatic System”: A New Approach to Reduce Interstitial Hypertension and Increase Blood Flow, pH and pO2 in Solid Tumors

  2000cited by this paper
• Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade.

  2000cited by this paper
• Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood.

  2000cited by this paper
• Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules.

  1999cited by this paper
• Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.

  1999cited by this paper
• Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity.

  1999cited by this paper
• Measurement of molecular diffusion in solution by multiphoton fluorescence photobleaching recovery.

  1999cited by this paper
• Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications.

  1999cited by this paper
• Stromal reaction in cancer tissue: Pathophysiologic significance of the expression of matrix‐degrading enzymes in relation to matrix turnover and immune/inflammatory reactions

  1998cited by this paper
• Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment.

  1998cited by this paper
• Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger.

  1998cited by this paper
• Human cells unable to express decoron produced disorganized extracellular matrix lacking "shape modules" (interfibrillar proteoglycan bridges).

  1998cited by this paper
• Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.

  1997cited by this paper
• The biology of vascular endothelial growth factor.

  1997cited by this paper
• Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).

  1997cited by this paper
• Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth

  1996cited by this paper
• Endogenous tumor necrosis factor inhibits the cytotoxicity of exogenous tumor necrosis factor and adriamycin in pancreatic carcinoma cells.

  1996cited by this paper
• Bradykinin and nitric oxide in infectious disease and cancer.

  1996cited by this paper
• TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis.

  1996cited by this paper
• Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.

  1995cited by this paper
• Specific binding of endocrine transforming growth factor-beta 1 to vascular endothelium.

  1995cited by this paper
• Fluorescence photobleaching with spatial Fourier analysis: measurement of diffusion in light-scattering media.

  1993cited by this paper
• Augmentation of tumour delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure.

  1993cited by this paper
• Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats.

  1993cited by this paper
• Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice.

  1993cited by this paper
• Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.

  1990cited by this paper
• Flow through interstitium and other fibrous matrices.

  1987cited by this paper
• Microvascular permeability of normal and neoplastic tissues.

  1986cited by this paper
• A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

  1986cited by this paper
• A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II.

  1981cited by this paper
• Physiological function of connective tissue polysaccharides.

  1978cited by this paper

• A Comprehensive Review on Etoposide: A Potent Chemotherapeutic Agent

  2025cites this paper
• Innovative System for Delivering Nucleic Acids/Genes Based on Controlled Intracellular Trafficking as Well as Controlled Biodistribution for Nanomedicines.

  2023cites this paper
• Long acting injectables for therapeutic proteins.

  2022cites this paper
• E. coli Nissle 1917-Derived Minicells for Targeted Delivery of Chemotherapeutic Drug to Hypoxic Regions for Cancer Therapy

  2018cites this paper
• Involvement of Tumor Lymphatic System in Translocation of Intratumorally Injected Liposomes.

  2018cites this paper
• Rational Approaches for Combination Therapy Strategies Targeting the MAP Kinase Pathway in Solid Tumors

  2018cites this paper
• Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery

  2017cites this paper
• Pet Imaging Of Early Therapeutic Response In Solid Tumors

  2017cites this paper
• Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation

  2017cites this paper
• Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system.

  2016cites this paper
• Impact of anti-PEG IgM antibodies on the pharmacokinetics of pegylated asparaginase preparations in mice.

  2016cites this paper
• Remodeling of the Extracellular Matrix by Endothelial Cell-Targeting siRNA Improves the EPR-Based Delivery of 100 nm Particles.

  2016cites this paper
• Drug Release is Determined by the Chain Length of Fatty Acid-Conjugated Anticancer Agent as One Component of Nano-Prodrug

  2016cites this paper
• Dendritic nanoconjugates of photosensitizer for targeted photodynamic therapy.

  2015cites this paper
• Intra-tumor distribution of PEGylated liposome upon repeated injection: No possession by prior dose.

  2015cites this paper
• Tumor Cell–Targeted Delivery of Nanoconjugated Oligonucleotides in Composite Spheroids

  2014cites this paper
• Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles.

  2014cites this paper